Bio-Rad Laboratories Inc (BIO) Stock Down 3.0% but Still Overvalued -- GF Score: 73/100

gurufocus.com · 2026-10-16

On October 16, 2026, Bio-Rad Laboratories Inc (BIO) shares fell by 3.0%, bringing the current price to $353.70. The stock has experienced a 52-week range of $23

TickrTrends take: Bio-Rad Laboratories operates in the Healthcare sector where valuation multiples can fluctuate significantly based on product performance and market conditions. Despite the recent 3 percent stock decline, TickrTrends continues to assess the company as overvalued, suggesting that current price levels remain elevated relative to fundamental metrics even after the selloff. Investors focused on valuation should monitor whether further price adjustments occur or if the company's financial metrics shift to justify its current market position.

Read the full story at gurufocus.com →